Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Frequency of arrhythmia symptoms and acceptability of implantable cardiac monitors in Hemodialysis patients.

El Hage N, Jaar BG, Cheng A, Knight C, Blasco-Colmenares E, Gimenez L, Guallar E, Shafi T.

BMC Nephrol. 2017 Oct 10;18(1):309. doi: 10.1186/s12882-017-0740-1.

2.

eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, Sarnak MJ, Shlipak MG, Sotoodehnia N, Young B, Heckbert SR.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1386-1398. doi: 10.2215/CJN.01860217. Epub 2017 Aug 10.

PMID:
28798221
3.

Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?

Nayak-Rao S, Shenoy MP.

Indian J Nephrol. 2017 May-Jun;27(3):167-171. doi: 10.4103/0971-4065.202405. Review.

4.

Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview.

Kulkarni N, Gukathasan N, Sartori S, Baber U.

J Atr Fibrillation. 2012 Jun 15;5(1):448. doi: 10.4022/jafib.448. eCollection 2012 Jun-Jul. Review.

5.

Atrial Fibrillation and Oral Anticoagulation in Chronic Kidney Disease.

Engelbertz C, Reinecke H.

J Atr Fibrillation. 2012 Apr 14;4(6):445. doi: 10.4022/jafib.445. eCollection 2012 Apr-May. Review.

6.

Pathophysiology of the cardio-renal syndromes types 1-5: An uptodate.

Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, Cozzolino M, Ronco C.

Indian Heart J. 2017 Mar - Apr;69(2):255-265. doi: 10.1016/j.ihj.2017.01.005. Epub 2017 Jan 22. Review.

7.

Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients.

Mavrakanas TA, Samer CF, Nessim SJ, Frisch G, Lipman ML.

J Am Soc Nephrol. 2017 Jul;28(7):2241-2248. doi: 10.1681/ASN.2016090980. Epub 2017 Mar 16.

PMID:
28302754
8.

A hemodialysis cohort study of protocol-based anticoagulation management.

Lamontagne S, Basein T, Chang B, Mallela L.

BMC Res Notes. 2017 Jan 26;10(1):66. doi: 10.1186/s13104-017-2381-7.

9.

Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease.

Tan J, Bae S, Segal JB, Zhu J, Segev DL, Alexander GC, McAdams-DeMarco M.

J Nephrol. 2017 Dec;30(6):831-839. doi: 10.1007/s40620-016-0374-6. Epub 2017 Jan 24.

PMID:
28120282
10.

Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).

Königsbrügge O, Posch F, Antlanger M, Kovarik J, Klauser-Braun R, Kletzmayr J, Schmaldienst S, Auinger M, Zuntner G, Lorenz M, Grilz E, Stampfel G, Steiner S, Pabinger I, Säemann M, Ay C.

PLoS One. 2017 Jan 4;12(1):e0169400. doi: 10.1371/journal.pone.0169400. eCollection 2017.

11.

National Trends and Impact of Acute Kidney Injury Requiring Hemodialysis in Hospitalizations With Atrial Fibrillation.

Chan L, Mehta S, Chauhan K, Poojary P, Patel S, Pawar S, Patel A, Correa A, Patel S, Garimella PS, Annapureddy N, Agarwal SK, Gidwani U, Coca SG, Nadkarni GN.

J Am Heart Assoc. 2016 Dec 20;5(12). pii: e004509. doi: 10.1161/JAHA.116.004509.

12.

Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.

Yang F, Hellyer JA, Than C, Ullal AJ, Kaiser DW, Heidenreich PA, Hoang DD, Winkelmayer WC, Schmitt S, Frayne SM, Phibbs CS, Turakhia MP.

Heart. 2017 Jun;103(11):818-826. doi: 10.1136/heartjnl-2016-309266. Epub 2016 Nov 15.

PMID:
27852694
13.

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.

McCullough PA, Ball T, Cox KM, Assar MD.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2079-2084. Epub 2016 Oct 25.

14.

Rationale and study design of the prospective, longitudinal, observational cohort study "rISk strAtification in end-stage renal disease" (ISAR) study.

Schmaderer C, Tholen S, Hasenau AL, Hauser C, Suttmann Y, Wassertheurer S, Mayer CC, Bauer A, Rizas KD, Kemmner S, Kotliar K, Haller B, Mann J, Renders L, Heemann U, Baumann M.

BMC Nephrol. 2016 Oct 26;17(1):161.

15.

Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.

Verde E, Pérez de Prado A, López-Gómez JM, Quiroga B, Goicoechea M, García-Prieto A, Torres E, Reque J, Luño J.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2210-2217. Epub 2016 Oct 3.

PMID:
27697781
16.

Cardiovascular complications in chronic dialysis patients.

Mavrakanas TA, Charytan DM.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):536-544.

17.

Investigation of selection bias in the association of race with prevalent atrial fibrillation in a national cohort study: REasons for Geographic And Racial Differences in Stroke (REGARDS).

Thacker EL, Soliman EZ, Pulley L, Safford MM, Howard G, Howard VJ.

Ann Epidemiol. 2016 Aug;26(8):534-539. doi: 10.1016/j.annepidem.2016.06.012. Epub 2016 Jul 13.

18.

Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.

Dember LM, Archdeacon P, Krishnan M, Lacson E Jr, Ling SM, Roy-Chaudhury P, Smith KA, Flessner MF.

J Am Soc Nephrol. 2016 Oct;27(10):2955-2963. Epub 2016 Jul 11. Review.

19.

Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.

Nochaiwong S, Ruengorn C, Awiphan R, Dandecha P, Noppakun K, Phrommintikul A.

Open Heart. 2016 Jun 16;3(1):e000441. doi: 10.1136/openhrt-2016-000441. eCollection 2016.

20.

The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials.

Caluwé R, Pyfferoen L, De Boeck K, De Vriese AS.

Clin Kidney J. 2016 Apr;9(2):273-9. doi: 10.1093/ckj/sfv146. Epub 2015 Dec 29.

Supplemental Content

Support Center